My bookmarksSign up free

Commission Implementing Regulation (EU) 2025/2154 Article 46

Commission Implementing Regulation (EU) 2025/2154 Article 46

Testing

Article 46

1.   Appropriate laboratory tests to determine conformity to specifications shall be conducted for each batch of active substance and intermediates thereof. 2.   An impurity profile describing the identified and unidentified impurities present in a typical batch produced by a specific controlled production process shall be established for each active substance. The impurity profile shall include: (a) the identity of the impurity or some qualitative analytical designation (e.g. retention time); (b) the range of each identified impurity; (c) a classification of each identified impurity (e.g. inorganic, organic, solvent). 3.   By way of derogation from paragraph 2, impurity profiles are not necessary for active substances from herbal or animal tissue origin. 4.   The impurity profile shall be compared at appropriate intervals against the impurity profile in the terms of the marketing authorisation or compared against historical data in order to detect changes to the active substance resulting from modifications in raw materials, equipment operating parameters, or the production process. 5.   Appropriate microbiological tests shall be conducted on each batch of intermediate and active substance where microbial quality is specified.

Read the full instrument → · Read this in context: CHAPTER XI — LABORATORY CONTROLS →

Other provisions in CHAPTER XI — LABORATORY CONTROLS

Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗ · Data as of 2026-07-04

CitationArticle 46 of Commission Implementing Regulation (EU) 2025/2154 (LawPlayer, data as of 2026-07-04)

© European Union, https://eur-lex.europa.eu, 1998-2026. Reuse authorised under Commission Decision 2011/833/EU, provided the source is acknowledged.

What to look at next